SYRE
SYRE
NASDAQ · Biotechnology

Spyre Therapeutics Inc

$42.77
+1.52 (+3.68%)
As of Mar 24, 1:30 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 20 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +84.5% upside
Low Target $58.92
Average Target $78.92
High Target $128.60
Current Price $42.77
Current
$42.77
Target
$78.92
$58.92 $78.92 avg $128.60
Scenario Analysis
Bear Case
$58.92
37.8%
Low target
Base Case
$78.92
+84.5%
Avg target
Bull Case
$128.60
+200.7%
High target
Risk/Reward
5.3x
Highly favorable
Price in Context
52-Week High
$38.16
12.1% from high
52-Week Low
$10.91
+292.0% from low
50-Day SMA
$33.24
+28.7% vs SMA
200-Day SMA
$22.06
+93.9% vs SMA
RSI (14)
64.7
Neutral
Target vs 52W High
$78.92
+106.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -26.5%